BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

This Sources Sought Notice (SSN) / Request for Information (RFI) is issued by BARDA to refine requirements for vaccine medical countermeasures for pandemic influenza preparedness and response, with consideration for establishing long-term partnerships with multiple contractors. Contractors will be expected to furnish all necessary resources – personnel, materials, facilities (U.S. facilities preferred) – to provide MCMs, produce antigen and vaccines against influenza and related viruses, support vaccine improvement efforts, and facilitate rapid regulatory submissions to the FDA. A mandatory eligibility criterion for award is the ability to produce influenza vaccines, demonstrated by either holding a U.S. influenza vaccine license or having submitted a Biologics License Application (BLA) for seasonal or pandemic influenza vaccine. Failure to document compliance with this requirement will result in elimination from consideration. BARDA seeks information to better understand the current state of the science in this field.

Notice ID

00d139c6a6c949ae8dd069d36de28667

Solicitation Number

75A50126R00001_RFI_SSN_NPIVS-2027

NAICS Code

541714

Classification Code

AN12